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ABSTRACT: A three-step procedure for the enantioselective synthesis of spiro[indolizidine-1,3´-oxindoles], consisting of a stere-
oselective cyclocondensation reaction between (S)-tryptophanol and a prochiral or racemic -oxoester, bromination of the resulting 
oxazolopiperidone lactam, and a final stereoselective spirocyclization, is reported. 
The tetracyclic spiro[indolizidine-1,3’-oxindole] ring system is 
a ubiquitous structural motif present in over one hundred 
indole alkaloids,
1
 some of them isolated from plant species 
used in traditional Oriental medicine
2
 (Figure 1). Many of 
these oxindole alkaloids, as well as those containing the more 
simple tricyclic spiro[pyrrolidine-3,3’-oxindole] moiety, show 
interesting biological activities
3
 and have inspired the devel-
opment of new potential therapeutic agents.
4
 For the above 
reasons, and also because of their complex molecular architec-





Figure 1. Representative bioactive oxindole alkaloids. 
A well-established procedure for the asymmetric construction 
of the spiro[indolizidine-1,3’-oxindole] framework is the 
biomimetic oxidative rearrangement of indolo[2,3-
a]quinolizidine derivatives.
6
 Another approach involves the 
use of intramolecular Mannich reactions of iminium ions 
derived from 2-hydroxytryptamines. Although the latter reac-
tions have been extensively used to generate tricyclic spi-
ro[pyrrolidine-3,3’-oxindoles],
7
 with the exception of the 
pioneering work by van Tamelen almost fifty years ago,
8 
they 




tive organocatalytic version of this methodology, via cyclic N-
acyl iminium ions derived from 2-halotryptamines, has recent-
ly been explored.
10
 However, in spite of all the synthetic ef-
forts in the field, the development of direct and efficient stere-
oselective methodologies to access enantiopure spi-
ro[indolizidine-1,3’-oxindoles], with their characteristic all-
carbon spiro stereocenter vicinal to another stereogenic center, 
still remains a challenging synthetic goal.  
In previous work, we have reported
11
 stereoconvergent cy-
clocondensation reactions between tryptophanol and -oxo 
esters A, either prochiral or as mixtures of stereoisomers, 
leading to enantiopure oxazolopiperidone lactams B, which 
can undergo three complementary regio- and stereocontrolled 





 E (Scheme 
1). 
The spirocyclization reaction occurs with complete regio- and 
stereocontrol by treatment of the lactam with TFA or a Lewis 
acid (TiCl4, BF3·Et2O) in the presence of Et3SiH. The success 
of the reaction depends on the presence of a deactivating aryl-
sulfonyl group on the indole nitrogen. The N-acyl iminium ion 
resulting from the oxazolidine ring-opening attacks the indole 
3-position to generate a spiroindoleninium intermediate, which 
 
 
Scheme 1. Complementary Types of Cyclization from 
Tryptophanol-Derived Lactams 
 
after trapping by Et3SiH affords a single spiroindoline in ex-
cellent yield. The reaction involves the generation of two 
contiguous stereogenic centers, one of them quaternary. 
With a procedure in hand for the direct assembly of enanti-
opure spiro[indoline-3,1’-indolizidines], access to the corre-
sponding spirooxindoles would simply require the oxidation of 
the indoline moiety. This was satisfactorily accomplished 
using iodosobenzene as the oxidant.
14
 Under these conditions, 
the oxidation of N-unsubstituted O-protected spiroindolines 2 
and 4 provided the respective oxindoles 5 and 6 in yields 
higher than 70% (Scheme 2). The procedure was also success-
fully applied to spiroindolines 8a and 8b, which lack the hy-
droxymethyl chain, to give the corresponding tetracyclic spi-
rooxindoles 9a and 9b, the latter being an advanced intermedi-




Scheme 2. Oxidation of Spiro[indoline-3,1'-indolizidines] 
to Spirooxindoles 
 
Although the above oxidations satisfactorily led to spi-
ro[indolizidine-1,3’oxindoles], we decided to explore alterna-
tive procedures that would allow direct access to these tetracy-
clic derivatives by spirocyclization of tryptophanol-derived 
oxazolopiperidone lactams. Despite the failure of previous 
efforts to build this tetracyclic spiro system by intramolecular 
Mannich reaction between a 2-oxo-2,3,4,5-tetrahy-
dropyridinium cation and an oxindole,
10a,b
 we decided to in-
vestigate the spirocyclization of lactam 11. The oxindole moi-
ety of this masked N-acyl iminium cation was generated in 
excellent yield by NCS oxidation of the indole ring of tryp-
tophanol-derived lactam 10a. After some unsuccessful at-
tempts (TFA, CH2Cl2, rt; aq HCl, reflux), gratifyingly, the 
desired spirocyclization occurred by treatment of 11 (mixture 
of epimers) with HCl/EtOH at 40 ºC to afford in 73% yield a 
mixture (6:4 ratio) of spirooxindole 12a and its C-7 epimer 
(Scheme 3). 
 
Scheme 3. Generation of a Spirooxindole by Intramolecu-
lar Attack of an N-Acyl Iminium Ion to an Oxindole 
 
This promising result prompted us to search for more stereose-
lective spirocyclizations leading to spiro[indolizidine-3,1’-
oxindoles]. We focused our attention on the spirocyclization 
of 2-bromoindoles 13,
16
 which were easily accessible by Py-
HBr3-promoted bromination
17
 of tryptophanol-derived lactams 
10 (Scheme 4). To our delight, treatment of 13a with TFA at rt 
for 24 h provided spirooxindole 12a in 87% yield as a single 
stereoisomer. The same result was obtained from the 8a-
epimer of 13a, thus making evident that spirocyclization oc-
curs via the N-acyl iminium cation resulting from the opening 
of the oxazolidine ring. Similarly, bromolactam 13b, which 
incorporates a substituent at the piperidone 4-position, was 
stereoselectively converted to a single oxindole 12b in 71% 
yield. 
The procedure was also applied to bromolactams 13c-e, sub-
stituted at the piperidone 5-position, although in these cases 
the corresponding spirooxindoles 12c-e
18
 were obtained to-
gether with minor amounts of the respective epimers at the 
spiro carbon.
19
 The relative stereochemistry of the spiro car-
bon in these epimers can be assigned by 
1
H NMR from the 
shielding (0.23-0.35 ppm) of the aromatic H-9 proton caused 
by the nearby piperidone carbonyl group in the major 7R epi-
mers 12c-e (also 14a,b; see below). 
Interestingly, the use of NBS/AIBN
20
 in the bromination of 
lactams 10a and 10b resulted in the direct generation of spi-
rooxindoles 14 (with minor amounts of the corresponding C-7 
epimers),
18 
in which the hydroxy group of the hydroxymethyl 
substituent had undergone substitution by bromine (Scheme  
 
Scheme 4. Access to Spiro[indolizidine-1,3’-oxindoles] from 2-Bromoindoles 
 
Scheme 5. Direct Generation of Spirooxindoles 
 
5). Due to the low yields, these conditions were not further 
explored. 
To expand the scope of the methodology, we applied it to 
tryptophanol-derived lactams bearing a substituent at the 8a 
position. The required lactams 17 were prepared by cyclocon-
densation of (S)-tryptophanol with ketoacids 15, followed by 
bromination with PyHBr3 (Scheme 6). A subsequent treatment 
of 17a or 17b with TFA stereoselectively provided the respec-
tive tetracyclic spirooxindoles 18a or 18b, in a process that 
involves the generation of two contiguous quaternary stereo-
genic centers.
18
 In contrast, a similar treatment from the phe-
nyl-substituted lactam 17c did not bring about the spirocy-
clization, and only caused the conversion of the 2-
bromoindole moiety to an oxindole, leading to 19c.
21
 
A rationale for the origin of the stereoselectivity in the above 
spirocyclizations to either spiroindolines or spirooxindoles is 
provided in Scheme 7, which highlights the decisive role 
played by the hydroxymethyl group as an element of stere-
ocontrol. The initially formed N-acyl iminium cation ap-
proaches the indole 3-position under stereoelectronic control
22
 
as depicted in conformation X1, via a transition state that 
avoids the interaction between the carbonyl and hydroxyme-
thyl groups (see Y). The electrophilic attack occurs from the Si 
face of the iminium cation, thus originating the R configura-
tion at C-3. On the other hand, in conformation X1 the indole 
ring is oriented in a way that it allows an antiperiplanar ar-
rangement of the -bonds system involved in the spirocycliza-
tion, (in contrast with conformation X2), thus determining the 
R configuration at the spiro carbon. Theoretical calculations 
(M062X/6-31G(d) combined with solvation effects using the 
MST method)
23
 confirmed that spirocyclization of F (R1 = 
C6H5SO2; X = R2 = H) involving conformation X1 is kinetical-
ly favored over cyclizations involving X2- or Y-type confor-
mations (see Supporting Information). 
 
Scheme 6. Access to Spiro[indolizidine-1,3’-oxindoles] 
Bearing Two Contiguous Quaternary Stereocenters 
 
Scheme 7. Stereochemical Outcome of the Spirocyclization 
 
 
In conclusion, we have reported a straightforward procedure 
for the enantioselective synthesis of spiro[indolizidine-3,1’-
oxindoles] from (S)-tryptophanol and prochiral or racemic -
oxoesters. In only three synthetic steps, a stereoselective cy-
clocondensation reaction, bromination of the resulting oxazol-
opiperidone lactam, and a final stereoselective spirocycliza-
tion, the procedure provides practical access to enantiopure 
tetracyclic spirooxindoles containing up to three contiguous 
stereogenic centers, or even two adjacent quaternary stereo-
centers. 
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